Virtual Group Visits for Type 2 Diabetes
(VIDA Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Virtual Group Visits for Type 2 Diabetes?
Is it safe to participate in virtual group visits for diabetes management?
How is the Virtual Group Visit treatment for type 2 diabetes different from other treatments?
Virtual Group Visits for type 2 diabetes are unique because they combine group education and individual medical consultations in a virtual setting, providing patients with social support and frequent contact with healthcare providers. This approach is different from traditional treatments as it leverages telehealth to improve patient engagement, diabetes knowledge, and emotional support, especially beneficial for those with limited access to in-person care.248910
What is the purpose of this trial?
The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).
Research Team
Arshiya Baig, MD
Principal Investigator
University of Chicago
Eligibility Criteria
This trial is for adults over 18 with type 2 diabetes and an A1C level above 8%, who also have a cardiovascular condition like high blood pressure, heart disease, or obesity. Participants must be from certain clinics, speak English or Spanish, and their primary care doctor must agree to their involvement.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend 6 monthly virtual group visits hosted by ACCESS or Advocate research staff
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Virtual Group Visit
Virtual Group Visit is already approved in United States for the following indications:
- Type 2 Diabetes Mellitus (T2DM)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
Wake Forest University Health Sciences
Collaborator
ACCESS Community Health Network
Collaborator
Advocate Health Care
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Midwest Clinicians' Network
Collaborator